肠易激综合征与全髋/全膝关节置换术后假体周围感染风险
本研究基于大型全国数据库,将19,102例有肠易激综合征(IBS)病史的患者与无IBS病史者按1:1倾向性评分匹配,评估全髋关节置换术(THA)和全膝关节置换术(TKA)术后2年假体周围感染(PJI)和再手术率。结果显示IBS整体与THA或TKA术后PJI及再手术率升高无关,但TKA术后接受IBS处方药的患者PJI和再手术风险升高。
要点
- IBS整体不增加THA或TKA术后2年PJI及再手术风险。
- TKA术后接受IBS药物治疗者PJI风险升高(OR 1.53)。
- TKA术后接受IBS药物治疗者再手术风险升高(OR 1.68)。
核心结论
- IBS与THA或TKA术后PJI及再手术率升高无关联。
- 但TKA术后接受IBS处方药的患者PJI和再手术风险升高。
研究设计与样本
- 使用大型全国数据库识别接受THA或TKA的患者。
- 将无IBS病史的对照队列与有IBS病史的实验队列按1:1倾向性评分匹配。
- 共19,102例有IBS病史,其中7,144例接受THA,11,958例接受TKA。
- 评估2年PJI和再手术率,并在IBD队列中重复分析作内部比较。
- 按是否接受IBS处方药对IBS队列进行亚组分析。
主要发现
- IBS和IBD队列在THA术后2年PJI和再手术风险上无差异(P > 0.05)。
- TKA术后IBD与2年PJI风险升高相关(OR 1.30,95%CI 1.02-1.64,P=0.031),但与再手术无关。
- TKA术后IBS队列整体在2年PJI和再手术上无差异(P > 0.05)。
- TKA术后接受IBS药物的患者2年PJI风险升高(OR 1.53,95%CI 1.11-2.10,P=0.009)。
- TKA术后接受IBS药物的患者再手术风险升高(OR 1.68,95%CI 1.14-2.46,P=0.008),THA术后无此关联。
关键数值与推荐
- TKA术后IBD与2年PJI风险升高相关(OR 1.30,95%CI 1.02-1.64,P=0.031)。
- TKA术后接受IBS药物的患者2年PJI风险升高(OR 1.53,95%CI 1.11-2.10,P=0.009)。
- TKA术后接受IBS药物的患者再手术风险升高(OR 1.68,95%CI 1.14-2.46,P=0.008)。
临床怎么用
- 对IBS患者行THA或TKA时,整体PJI风险未见显著升高。
- TKA术前应关注IBS患者是否使用处方药,可能提示疾病更重、PJI风险更高。
局限性
- 需要进一步研究阐明IBS与PJI之间的关系。
- 证据等级为III级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Past studies have shown that inflammatory bowel disease (IBD) is associated with increased periprosthetic joint infection (PJI) risk, but none have investigated the risk in irritable bowel syndrome (IBS). The purpose of this study was to evaluate the risk of PJI following total hip arthroplasty (THA) and total knee arthroplasty (TKA) in patients who have IBS. METHODS: Patients who underwent THA or TKA were identified using a large national database. Control cohorts of patients who did not have a history of IBS were 1:1 propensity score matched to experimental cohorts of patients who have IBS. A total of 19,102 patients had a history of IBS, of which 7,144 underwent THA and 11,958 underwent TKA. The 2-year PJI and reoperation rates were assessed. Data analyses were repeated in IBD cohorts for internal comparisons. Subgroup analyses stratified IBS cohorts by receipt of IBS prescription medications. RESULTS: There were no differences in risk of 2-year PJI and reoperations following THA in IBS and IBD cohorts (P > 0.05). Following TKA, IBD was associated with increased risk of 2-year PJI (odds ratio [OR]: 1.30, 95% confidence interval [CI]: 1.02 to 1.64, P = 0.031), but not reoperations; however, there were no differences among IBS cohorts (P > 0.05). Patients who have IBS and received medication had an elevated risk of 2-year PJI (OR: 1.53, 95% CI: 1.11 to 2.10, P = 0.009) and reoperations (OR: 1.68, 95% CI: 1.14 to 2.46, P = 0.008) following TKA, but not THA. CONCLUSIONS: There were no associations observed between IBS and increased PJI and reoperation rates after THA or TKA. However, IBS patients who were prescribed medications, potentially reflecting greater disease severity, were associated with increased risk of PJI and reoperation following TKA. Further research is needed to clarify the relationship between IBS and PJI. LEVEL OF EVIDENCE: III.
引用
- Tan D, Anderson B, Kesick A, et al. Irritable Bowel Syndrome and Periprosthetic Joint Infection Risk Following Total Hip and Knee Arthroplasty. J Arthroplasty. 2026. PMID: 42537953. doi:10.1016/j.arth.2026.07.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。